Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stressMasanari Itokawa, Toshio Miyata, Tomoe Ichikawa et al.|Psychiatry and Clinical Neurosciences|2017Cited by 54
The regulation of soluble receptor for AGEs contributes to carbonyl stress in schizophreniaMitsuhiro Miyashita, Makoto Arai, Takuo Watanabe et al.|Biochemical and Biophysical Research Communications|2016Cited by 18
AKR1A1 Variant Associated With Schizophrenia Causes Exon Skipping, Leading to Loss of Enzymatic ActivityKyoka Iino, Makoto Arai, Kazuya Toriumi et al.|Frontiers in Genetics|2021Cited by 7
Role of advanced glycation end products in the longitudinal association between muscular strength and psychotic symptoms among adolescentsKazuhiro Suzuki, Makoto Arai, Syudo Yamasaki et al.|Schizophrenia|2022Cited by 4